Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would not wait. This is a textbook “patient safety + material disclosure” crisis. The right move is rapid, documented, regulator-first action. Immediate stance (set at Hour 0) Patient safety first (interim risk controls now, not after perfect certainty).Read the full answer
You have a patient safety issue, not a PR issue. The 6 month regulatory reporting timeline is the formal process, not the ethical or legal obligation to act now. Waiting for more data while patients continue to be exposed is criminal negligence exposure, not risk mitigation.Read the full answer